Centene Corporation CNC
- Market cap
- $30.6B
- P/E
- 0.0×
Follow CNC
Centene Corporation (CNC) Price to free cash flow
As of 25 September 2026, Centene Corporation (CNC) trades at a price to free cash flow of 3.4×. Over the past ten years it has ranged from 0.0× (March 2025) to 337× (April 2019); the current reading is higher than 7% of that period. That is below the Healthcare Plans industry median of 11.1× and below the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 4.7× | — |
| FY2024 | 0.0× | — |
| FY2023 | 5.8× | (34.04%) |
| FY2022 | 8.7× | (40.14%) |
| FY2021 | 14.6× | 97.14% |
| FY2020 | 7.4× | (78.58%) |
| FY2019 | 34.5× | (14.22%) |
| FY2018 | 40.2× | 142.74% |
| FY2017 | 16.6× | 175.27% |
| FY2016 | 6.0× | (60.97%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 3.5× | 56.33% |
| Mar 2026 | 2.3× | (51.76%) |
| Dec 2025 | 4.7× | (10.07%) |
| Sep 2025 | 5.2× | (78.95%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.0× |
| CNC Centene Corporation | 3.4× |
| CI Cigna Group compare | 7.8× |
| CVS CVS Health Corporation compare | 9.7× |
| ELV Elevance Health, Inc. compare | 13.7× |
| UNH UnitedHealth Group Incorporated compare | 14.4× |
| HUM Humana Inc. compare | 24.2× |
| CLOV Clover Health Investments, Corp. compare | 31.7× |
| MOH Molina Healthcare, Inc compare | 36.0× |
| Healthcare Plans industry median | 11.1× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on CNC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement